Enhanced Vancomycin Hemodialysis model now available in DoseMeRx!Learn more →

Cracking the PK Code: The Art of Precision Beta-lactam Dosing  

Featured speakers

Marc H. Scheetz, PharmD, MSc, FCCP, FCP

Associate Dean of Research, Director of Pharmacometrics Center of Excellence – Midwestern University/Northwestern Medicine

Will Musick

Will Musick, PharmD, BCIDP

Clinical Specialist in Infectious Diseases, Program Director, PGY2 ID Residency – Houston Methodist

β-lactam antibiotics remain a cornerstone of therapy against serious bacterial infections. However, standard dosing approaches fail to account for the complexity of critically ill patients. Significant PK variability in the ICU leads to inadequate exposure and treatment failures. 

This webinar explores how clinicians can elevate patient care through personalized β-lactam dosing. By considering each patient’s unique profile, precision strategies can improve outcomes, reduce resistance, and ensure therapy is optimized.

What you’ll learn

  • The growing threat of resistance and PK/PD principles for β-lactam optimization
  • Evidence for exposure variability and individualized TDM
  • Patient cases showing model-informed precision dosing in action
  • Practical approaches to integrating pharmacokinetics and achieving clinical targets
  • OPAT transitions and maintaining efficacy from hospital to home

Watch the recording

Meet the speakers

Marc H. Scheetz, PharmD, MSc, FCCP, FCP

Dr. Marc Scheetz is a Professor at Midwestern University in the Chicago College of Pharmacy, holds a joint appointment in the Department of Pharmacology, College of Graduate Studies, & is the Director of the Pharmacometric Center of Excellence at Midwestern University. He practices clinically as an ID pharmacist at Northwestern Memorial Hospital & serves as the Director for the Post-Doctoral Fellowship Program in Infectious Diseases Pharmacotherapy. He has authored over 190 original research manuscripts & review articles in the area of anti-infective pharmacokinetics & pharmacodynamics & serves as a reviewer for several journals. His primary research interest lies in the interface of the pharmacokinetic/pharmacodynamic interaction. He is particularly interested in assessing modifiable pharmacologic variables in the treatment of infectious diseases & identifying optimal exposures against the backdrop of toxicity. Dr. Scheetz attained a Doctorate of Pharmacy from Butler University, a Masters of Science in Clinical Investigation degree at Northwestern University, & completed his pharmacy practice residency & an ID fellowship at Northwestern Memorial Hospital.

Will Musick

Will Musick, PharmD, BCIDP

Dr. Musick is Infectious Diseases Clinical Specialist at Houston Methodist Hospital (HMH) in Houston,TX. He focuses on the Solid-Organ Transplant and Critically Ill populations. He developed and directs the PGY2 Infectious Diseases residency program at HMH and holds adjunct faculty appointments to the University of Houston College of Pharmacy and the University of Texas College of Pharmacy. His professional interests include teaching/training residents and students and researching atypical infections and CMV in the solid-organ transplant population.


Drug models

Simplify TDM with clinically validated drug models in a wide range of therapeutic areas.

EHR integration

DoseMeRx’s secure, user-friendly platform works seamlessly with the widest range of hospital systems.

Solicita una demo

Mira cómo DoseMeRx trabaja y se integra en tu rutina de trabajo diaria.

Solicita una demo a continuación. Puedes telefonearnos al +1 (832) 358-3308 o email hello@dosemehealth.com.

Why should you choose DoseMeRx?

trusted by clincians
1:1 customer support

HIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2024 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.